Thompson Siegel & Walmsley LLC Pfizer Inc Transaction History
Thompson Siegel & Walmsley LLC
- $6.43 Billion
- Q4 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Pfizer Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 345,040 shares of PFE stock, worth $9.19 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
345,040
Previous 387,084
10.86%
Holding current value
$9.19 Million
Previous $11.2 Million
18.28%
% of portfolio
0.14%
Previous 0.17%
Shares
31 transactions
Others Institutions Holding PFE
# of Institutions
3,370Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.74 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.14 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.73 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $150B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...